Roth Capital Markets analyst Jonathan Aschoff has maintained his “Buy” rating and US$30.00 price target on Tenax Therapeutics ...
Livewire Markets on MSN
Last year's Sohn picks returned 38%. Here are the 9 new ideas from this year's conference
From steel and cement to UFC and AI software, nine fund managers share their highest conviction Sohn Hearts and Minds stock ...
Q3 Cash Collections of $10.0 million -Q3 Thyroid test volume up 12% year-over-year to record levels -Q3 Thyroid revenue of $8.8M; up 22% year-over-year to record levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback